Point72 Hong Kong LTD Vbi Vaccines Inc Transaction History

Point72 Hong Kong LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.73 - $23.4 $16,031 - $513,887	-21,961 Reduced 60.74%	14,193 $10,000
Q2 2022 Aug 15, 2022	BUY	$0.66 - $1.81 $23,861 - $65,438	36,154 New	36,154 $29,000
Q1 2022 May 16, 2022	SELL	$1.27 - $2.47 $23,379 - $45,470	-18,409 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.21 - $3.22 $40,683 - $59,276	18,409 New	18,409 $43,000
Q2 2021 Aug 16, 2021	SELL	$2.61 - $4.17 $10,552 - $16,859	-4,043 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$2.91 - $4.32 $11,765 - $17,465	4,043 New	4,043 $13,000
Q3 2020 Nov 16, 2020	SELL	$2.77 - $6.17 $27,231 - $60,657	-9,831 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$0.87 - $3.13 $8,552 - $30,771	9,831 New	9,831 $30,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.